Leptospirosis is a bacterial infection spread through contact with infected animal urine that can cause fever, headache, jaundice and other symptoms. It is more common in warm climates and transmitted through breaks in the skin or mucous membranes. Antibiotics are used to treat it, with more severe cases requiring hospitalization.
Severe Acute Respiratory Syndrome (SARS) is a viral pneumonia caused by a coronavirus. It is spread through droplets from coughs or sneezes of infected individuals or surfaces they touch. Prevention methods include handwashing, wearing masks around infected people, and disinfecting surfaces.
Chikungunya is a mosquito-borne viral disease caused by
Emerging and reemerging infectious diseasesarijitkundu88
Various emerging and reemerging diseases. Factors contributing to the emergence of infectious diseases. Antibiotic resistance. The global response to control them. Laboratories network in surveillance.
Non-communicalbe diseases and its preventionShoaib Kashem
Non communicable disease account for a large and increasing burden of disease worldwide. It is currently estimated that non communicable disease accounts for approximately 60% of global deaths and 43% of global disease burden. This is projected to increase to 73% of deaths and 60% of disease burden by 2020.
Hello friends i am BSc Nursing intern.This presentation of mine covers almost each and every aspect related to swine flu.Hope it will help you to increase your knowledge regarding the topic.Looking forward to your feedback.Thank you
MAPEH 8 - Health 3rd Quarter
Chain of Infection and Stages of Infection
If you want a powerpoint copy of this, please look for the download link in the comment section :)
HIGHLIGHTS:
Lesson 10: Nature, Prevention and Control Communicable Disease
Lesson 11: Emerging and Re-emerging Infectious Disease
Lesson 12: Community Programs and Policies on Disease and Development of Self-Monitoring Skills
Lesson 13: Agencies and Referral Procedures for Communicable Disease, Prevention, and Control
Emerging and reemerging infectious diseasesarijitkundu88
Various emerging and reemerging diseases. Factors contributing to the emergence of infectious diseases. Antibiotic resistance. The global response to control them. Laboratories network in surveillance.
Non-communicalbe diseases and its preventionShoaib Kashem
Non communicable disease account for a large and increasing burden of disease worldwide. It is currently estimated that non communicable disease accounts for approximately 60% of global deaths and 43% of global disease burden. This is projected to increase to 73% of deaths and 60% of disease burden by 2020.
Hello friends i am BSc Nursing intern.This presentation of mine covers almost each and every aspect related to swine flu.Hope it will help you to increase your knowledge regarding the topic.Looking forward to your feedback.Thank you
MAPEH 8 - Health 3rd Quarter
Chain of Infection and Stages of Infection
If you want a powerpoint copy of this, please look for the download link in the comment section :)
HIGHLIGHTS:
Lesson 10: Nature, Prevention and Control Communicable Disease
Lesson 11: Emerging and Re-emerging Infectious Disease
Lesson 12: Community Programs and Policies on Disease and Development of Self-Monitoring Skills
Lesson 13: Agencies and Referral Procedures for Communicable Disease, Prevention, and Control
Swine Influenza is a respiratory disease that can affect humans. Prepare for flu outbreaks as you would for all hazards. Created and distributed courtesy of ReadyArmy.mil
The Coronavirus Disease 2019 (COVID-19) has taken the world by storm. COVID-19 is a member of the coronavirus family, which has never been detected in humans before. There are seven known strains of coronavirus (CoV). Coronaviruses are derived from a variety of animals. The virus has many similarities to Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The viruses can cause illnesses ranging from the common cold to more severe health complications.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
2. At the end of the day, students on their own
and in the long run, should be able to:
Familiarize with the different emerging and
re-emerging diseases.
Analyze the nature of emerging and
reemerging diseases
3.
4. Leptospira interrogans
It is carried by many animals and lives in their
kidneys.
It ends up in soil and water through their urine.
It can invade your body through breaks in your skin,
like scratches, open wounds, or dry areas.
It can also enter through your nose, mouth, or
genitals.
5. Leptospirosis is more often found in
warm climates.
And although the bacteria live all over
the world, it’s especially common in
Australia, Africa, Southeast Asia,
Central and South America, and the
Caribbean.
7. For mild cases, the doctor may prescribe antibiotics, such as
doxycycline or penicillin.
Patients with severe leptospirosis will need to spend time
in the hospital. They will receive antibiotics intravenously.
Depending on which organs leptospirosis affects, the
individual may need a ventilator to help them breathe.
If it affects the kidneys, dialysis may be necessary.
If it affects the brain or spinal cord, meningitis, encephalitis,
or both may develop.
8.
9. It was first identified at the end of February
2003 during an outbreak that emerged in China
and spread to 4 other countries.
An airborne virus and can spread through
small droplets of saliva in a similar way to the
cold and influenza.
It can also be spread indirectly via surfaces
that have been touched by someone who is
infected with the virus.
10. A serious form of viral pneumonia caused by the SARS
coronavirus
SARS can spread when an infected person comes into face-
to-face contact with someone else. Face-to-face contact
refers to:
1. caring for someone with SARS
2. having contact with the bodily fluids of a person with SARS
3. kissing, hugging, touching, or sharing eating or drinking
utensils with an infected person
The disease may also be spread through the air, but
researchers have not confirmed this.
11. Here are some of the best ways to prevent transmission of SARS if
you’re in close contact with someone who’s been diagnosed with
the disease:
1. Wash your hands frequently.
2. Wear disposable gloves if touching any infected bodily fluids.
3. Wear a surgical mask when in the same room with a person with
SARS.
4. Disinfect surfaces that may have been contaminated with the
virus.
5. Wash all personal items, including bedding and utensils, used by
a person with SARS.
12.
13. A mosquito-borne viral disease first described
during an outbreak in southern Tanzania in 1952.
When an uninfected mosquito feeds upon a viremic
person the mosquito can pick up the virus as it ingests
the blood.
It is caused by the chikungunya virus (CHIKV).
There is currently no vaccine or specific drug
against the virus. The treatment is focused on
relieving the disease symptoms.
14. The disease mostly occurs in Africa, Asia and the
Indian subcontinent. However a major outbreak in
2015 affected several countries of the Region of the
Americas, and sporadic outbreaks are seen
elsewhere.
Both Ae. aegypti and Ae. albopictus have been
implicated in large outbreaks of chikungunya.
Whereas Ae. aegypti is confined within the tropics
and sub-tropics, Ae. albopictus also occurs in
temperate and even cold temperate regions.
15. There is no specific antiviral drug treatment
for chikungunya. The clinical management
targets primarily to relieving the symptoms,
including the joint pain using anti-pyretics,
optimal analgesics, drinking plenty of fluids and
general rest.
Medicines such as paracetamol or
acetaminophen are recommended to pain relief
and reducing fever.
16.
17. A blood infection due to the bacteria Neisseria
meningitidis.
When someone has meningococcemia, bacteria
enter the bloodstream and multiply, damaging
blood vessels throughout the body and causing
bleeding into the skin and organs.
This can lead to a significant rash.
18. According to the Meningitis Research Foundation of Canada, up to
20% of people carry N. meningitidis in the back of their noses and
throats without having symptoms. Any carrier can transmit the
bacteria to other people.
The bacteria spread via direct contact with tiny droplets that come out
of a person’s nose or mouth. These droplets may reach another
person through:
1. coughing
2. sneezing
3. kissing
4. sharing cutlery or food
5. sharing drinks from the same container
6. sharing lipstick, cigarettes, or toothbrushes
19. Most cases of meningococcemia cause visible skin changes, along with
other symptoms. A person can detect signs of meningococcemia by
checking all over the body for a rash that does not fade when they
apply pressure.
In its earliest stages, meningococcal disease causes flu-like symptoms,
including:
1. fever and chills
2. fatigue (feeling tired)
3. cold hands and feet
4. muscle or joint pain
5. irritability
6. vomiting
7. rapid breathing
20.
21.
22. Who are the people most vulnerable to:
Leptospirosis
Severe Acute Respiratory Syndrome
Chikungunya
Meningococcemia
What places are at higher risk of having:
Leptospirosis cases
Severe Acute Respiratory Syndrome cases
Chikungunya cases
Meningococcemia cases